MEDAX | VGAVX | MEDAX / VGAVX | |
Total Expense Ratio | 1.06 | 0.20 | 530% |
Annual Report Gross Expense Ratio | 1.07 | 0.20 | 535% |
Fund Existence | 27 years | 12 years | - |
Gain YTD | 6.325 | 7.378 | 86% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.44B | 4.91B | 152% |
Annual Yield % from dividends | 5.63 | 6.22 | 90% |
Returns for 1 year | 8.79 | 9.60 | 92% |
Returns for 3 years | 25.25 | 23.73 | 106% |
Returns for 5 years | 8.50 | 5.62 | 151% |
Returns for 10 years | 41.15 | 42.25 | 97% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LUSIX | 10.91 | 0.07 | +0.65% |
Lazard US Systematic Small Cap Eq Ins | |||
SVTAX | 11.18 | 0.06 | +0.54% |
SEI Global Managed Volatility F (SIMT) | |||
BBTIX | 12.96 | 0.05 | +0.39% |
Bridge Builder Tax Managed Intl Eq | |||
PBCKX | 50.72 | 0.17 | +0.34% |
Principal Blue Chip Institutional | |||
ANDIX | 16.48 | 0.02 | +0.12% |
AQR International Defensive Style I |